Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statement of Changes in Stockholders' Equity (Deficiency)

v3.3.0.814
Interim Consolidated Statement of Changes in Stockholders' Equity (Deficiency) - USD ($)
Common Shares [Member]
Additional Paid-In Capital [Member]
Deficiency [Member]
Accumulated Other Comprehensive loss [Member]
Total
Beginning Balance at Nov. 30, 2013 $ 46,849 $ 23,226,988 $ (21,320,357)   $ 1,953,480
Beginning Balance (Shares) at Nov. 30, 2013 46,849,285        
Stock based compensation for issue of options   751,610     751,610
Exercise of options $ 50 12,450     12,500
Exercise of options (Shares) 50,000        
Relative fair value of placement agent warrants   33,583     33,583
Net loss for the period     (2,722,412)   (2,722,412)
Foreign currency translation       $ (31,706) (31,706)
Ending Balance at Nov. 30, 2014 $ 46,899 24,024,631 (24,042,769) (31,706) (2,945)
Ending Balance (Shares) at Nov. 30, 2014 46,899,285        
Issue of common shares $ 7,576 2,492,424     2,500,000
Issue of common shares (Shares) 7,575,757        
Exercise of options $ 35 6,960     6,995
Exercise of options (Shares) 35,000        
Exercise of warrants $ 106 16,669     16,775
Exercise of warrants (Shares) 105,600        
Net loss for the period     (1,425,013)   (1,425,013)
Foreign currency translation       (9,135) (9,135)
Ending Balance at Aug. 31, 2015 $ 54,616 $ 26,540,684 $ (25,467,782) $ (40,841) $ 1,086,677
Ending Balance (Shares) at Aug. 31, 2015 54,615,642